Review



gc 2 spd ts cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC gc 2 spd ts cells
    Gc 2 Spd Ts Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 261 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/10__1016_slash_j__ncrna__2026__04__001-50-10-17?v=ATCC
    Average 95 stars, based on 261 article reviews
    gc 2 spd ts cells - by Bioz Stars, 2026-07
    95/100 stars

    Images



    Similar Products

    95
    ATCC gc 2 spd ts cells
    Gc 2 Spd Ts Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/10__1016_slash_j__ncrna__2026__04__001-50-10-17?v=ATCC
    Average 95 stars, based on 1 article reviews
    gc 2 spd ts cells - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    99
    Thermo Fisher complete ts cell medium
    Complete Ts Cell Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/pm42007670-316-5-11?v=Thermo+Fisher
    Average 99 stars, based on 1 article reviews
    complete ts cell medium - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    ATCC human her2 female breast cancer cell lines bt474 ts
    Human Her2 Female Breast Cancer Cell Lines Bt474 Ts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/pm42115409-59-0-19?v=ATCC
    Average 99 stars, based on 1 article reviews
    human her2 female breast cancer cell lines bt474 ts - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    86
    Constant Systems Ltd ts series cell disruptor
    Ts Series Cell Disruptor, supplied by Constant Systems Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/pm41951885-238-18-22?v=Constant+Systems+Ltd
    Average 86 stars, based on 1 article reviews
    ts series cell disruptor - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Constant Systems Ltd cell disruptor ts series
    Cell Disruptor Ts Series, supplied by Constant Systems Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/bio_rxiv__64898__2026__03__30__714413-325-5-9?v=Constant+Systems+Ltd
    Average 86 stars, based on 1 article reviews
    cell disruptor ts series - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    95
    ATCC mouse spermatogonial gc 2spd cells
    A) RNA immunoprecipitation (RIP) from GC-2spc cells using SMG6 and PIWIL1 antibodies. Rabbit IgG was used as a negative control. Left panel shows Western blotting (WB) of SMG6 and PIWIL1. Right panel shows RT-PCR after IP using Ccny and Taf1d specific primers. B) Validation of the knockdown efficiency after transfection of small interfering RNA (siRNA) for Smg6 or Piwil1 (si-Smg6, si-Piwil1) <t>in</t> <t>GC-2spd</t> cells by RT-qPCR using Smg6 or Piwil1 primers. Scrambled siRNA was used as a negative control (si-Scr). C) Validation of the overexpression of SMG6 or PIWIL1 in GC-2spd cells using HA-SMG6 or FLAG-PIWIL1 expression plasmids, respectively. Empty pcdna3.1 vector as a control. D) RT-qPCR using Ccny and Taf1d -specific primers after siRNA-mediated downregulation of Smg6 or Piwil1 in GC-2spd cells. E) RT-qPCR using Ccny and Taf1d -specific primers after overexpression of HA-SMG6 or FLAG-PIWIL1 in GC-2spd cells. F) Overexpression of SMG6 (HA-SMG6) in GC-2spd cells in the presence or absence of Piwil1 knockdown by siRNA. RT-qPCR analysis of Ccny and Taf1d mRNAs was performed to assess whether PIWIL1 is required for SMG6-mediated regulation of these targets. G) Control (si-Scr) or PIWIL1 knockdown (si-Piwil1) GC-2spd cells were subjected to SMG6 RIP, followed by RT-qPCR to assess the association of SMG6 with Ccny and Taf1d mRNAs. Taf1d and Ccny transcripts were quantified and normalized to input RNA. Data represent mean ± S.D. from three independent experiments, *P < 0.05. H) Western blotting with anti-SMG6 antibody to validate equal IP of SMG6 from control (si-Scr) and Piwil1 -silenced (si- Piwil1) cells. Two representative IPs (RIP-1, RIP-2) are shown for both conditions. For all graphs (B-F), means of three independent experiments are shown, and Rpl19 was used as a reference gene. Data represent mean ± S.D. from three independent experiments, *P < 0.05.
    Mouse Spermatogonial Gc 2spd Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/bio_rxiv__64898__2026__03__26__714452-243-0-4?v=ATCC
    Average 95 stars, based on 1 article reviews
    mouse spermatogonial gc 2spd cells - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    86
    Constant Systems Ltd ts series continuous cell disruptor
    A) RNA immunoprecipitation (RIP) from GC-2spc cells using SMG6 and PIWIL1 antibodies. Rabbit IgG was used as a negative control. Left panel shows Western blotting (WB) of SMG6 and PIWIL1. Right panel shows RT-PCR after IP using Ccny and Taf1d specific primers. B) Validation of the knockdown efficiency after transfection of small interfering RNA (siRNA) for Smg6 or Piwil1 (si-Smg6, si-Piwil1) <t>in</t> <t>GC-2spd</t> cells by RT-qPCR using Smg6 or Piwil1 primers. Scrambled siRNA was used as a negative control (si-Scr). C) Validation of the overexpression of SMG6 or PIWIL1 in GC-2spd cells using HA-SMG6 or FLAG-PIWIL1 expression plasmids, respectively. Empty pcdna3.1 vector as a control. D) RT-qPCR using Ccny and Taf1d -specific primers after siRNA-mediated downregulation of Smg6 or Piwil1 in GC-2spd cells. E) RT-qPCR using Ccny and Taf1d -specific primers after overexpression of HA-SMG6 or FLAG-PIWIL1 in GC-2spd cells. F) Overexpression of SMG6 (HA-SMG6) in GC-2spd cells in the presence or absence of Piwil1 knockdown by siRNA. RT-qPCR analysis of Ccny and Taf1d mRNAs was performed to assess whether PIWIL1 is required for SMG6-mediated regulation of these targets. G) Control (si-Scr) or PIWIL1 knockdown (si-Piwil1) GC-2spd cells were subjected to SMG6 RIP, followed by RT-qPCR to assess the association of SMG6 with Ccny and Taf1d mRNAs. Taf1d and Ccny transcripts were quantified and normalized to input RNA. Data represent mean ± S.D. from three independent experiments, *P < 0.05. H) Western blotting with anti-SMG6 antibody to validate equal IP of SMG6 from control (si-Scr) and Piwil1 -silenced (si- Piwil1) cells. Two representative IPs (RIP-1, RIP-2) are shown for both conditions. For all graphs (B-F), means of three independent experiments are shown, and Rpl19 was used as a reference gene. Data represent mean ± S.D. from three independent experiments, *P < 0.05.
    Ts Series Continuous Cell Disruptor, supplied by Constant Systems Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ts+cells/pmc13194723-320-10-15?v=Constant+Systems+Ltd
    Average 86 stars, based on 1 article reviews
    ts series continuous cell disruptor - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    A) RNA immunoprecipitation (RIP) from GC-2spc cells using SMG6 and PIWIL1 antibodies. Rabbit IgG was used as a negative control. Left panel shows Western blotting (WB) of SMG6 and PIWIL1. Right panel shows RT-PCR after IP using Ccny and Taf1d specific primers. B) Validation of the knockdown efficiency after transfection of small interfering RNA (siRNA) for Smg6 or Piwil1 (si-Smg6, si-Piwil1) in GC-2spd cells by RT-qPCR using Smg6 or Piwil1 primers. Scrambled siRNA was used as a negative control (si-Scr). C) Validation of the overexpression of SMG6 or PIWIL1 in GC-2spd cells using HA-SMG6 or FLAG-PIWIL1 expression plasmids, respectively. Empty pcdna3.1 vector as a control. D) RT-qPCR using Ccny and Taf1d -specific primers after siRNA-mediated downregulation of Smg6 or Piwil1 in GC-2spd cells. E) RT-qPCR using Ccny and Taf1d -specific primers after overexpression of HA-SMG6 or FLAG-PIWIL1 in GC-2spd cells. F) Overexpression of SMG6 (HA-SMG6) in GC-2spd cells in the presence or absence of Piwil1 knockdown by siRNA. RT-qPCR analysis of Ccny and Taf1d mRNAs was performed to assess whether PIWIL1 is required for SMG6-mediated regulation of these targets. G) Control (si-Scr) or PIWIL1 knockdown (si-Piwil1) GC-2spd cells were subjected to SMG6 RIP, followed by RT-qPCR to assess the association of SMG6 with Ccny and Taf1d mRNAs. Taf1d and Ccny transcripts were quantified and normalized to input RNA. Data represent mean ± S.D. from three independent experiments, *P < 0.05. H) Western blotting with anti-SMG6 antibody to validate equal IP of SMG6 from control (si-Scr) and Piwil1 -silenced (si- Piwil1) cells. Two representative IPs (RIP-1, RIP-2) are shown for both conditions. For all graphs (B-F), means of three independent experiments are shown, and Rpl19 was used as a reference gene. Data represent mean ± S.D. from three independent experiments, *P < 0.05.

    Journal: bioRxiv

    Article Title: Chromatoid body integrates piRNA, SMG6 and m⁶A pathways to control mRNAs in the male germline

    doi: 10.64898/2026.03.26.714452

    Figure Lengend Snippet: A) RNA immunoprecipitation (RIP) from GC-2spc cells using SMG6 and PIWIL1 antibodies. Rabbit IgG was used as a negative control. Left panel shows Western blotting (WB) of SMG6 and PIWIL1. Right panel shows RT-PCR after IP using Ccny and Taf1d specific primers. B) Validation of the knockdown efficiency after transfection of small interfering RNA (siRNA) for Smg6 or Piwil1 (si-Smg6, si-Piwil1) in GC-2spd cells by RT-qPCR using Smg6 or Piwil1 primers. Scrambled siRNA was used as a negative control (si-Scr). C) Validation of the overexpression of SMG6 or PIWIL1 in GC-2spd cells using HA-SMG6 or FLAG-PIWIL1 expression plasmids, respectively. Empty pcdna3.1 vector as a control. D) RT-qPCR using Ccny and Taf1d -specific primers after siRNA-mediated downregulation of Smg6 or Piwil1 in GC-2spd cells. E) RT-qPCR using Ccny and Taf1d -specific primers after overexpression of HA-SMG6 or FLAG-PIWIL1 in GC-2spd cells. F) Overexpression of SMG6 (HA-SMG6) in GC-2spd cells in the presence or absence of Piwil1 knockdown by siRNA. RT-qPCR analysis of Ccny and Taf1d mRNAs was performed to assess whether PIWIL1 is required for SMG6-mediated regulation of these targets. G) Control (si-Scr) or PIWIL1 knockdown (si-Piwil1) GC-2spd cells were subjected to SMG6 RIP, followed by RT-qPCR to assess the association of SMG6 with Ccny and Taf1d mRNAs. Taf1d and Ccny transcripts were quantified and normalized to input RNA. Data represent mean ± S.D. from three independent experiments, *P < 0.05. H) Western blotting with anti-SMG6 antibody to validate equal IP of SMG6 from control (si-Scr) and Piwil1 -silenced (si- Piwil1) cells. Two representative IPs (RIP-1, RIP-2) are shown for both conditions. For all graphs (B-F), means of three independent experiments are shown, and Rpl19 was used as a reference gene. Data represent mean ± S.D. from three independent experiments, *P < 0.05.

    Article Snippet: Mouse spermatogonial GC-2spd cells (ATCC® CRL-2196TM, USA) were maintained in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12, D-18900; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, S1810; Biowest) and 1% penicillin–streptomycin (15140-122; Gibco).

    Techniques: RNA Immunoprecipitation, Negative Control, Western Blot, Reverse Transcription Polymerase Chain Reaction, Biomarker Discovery, Knockdown, Transfection, Small Interfering RNA, Quantitative RT-PCR, Over Expression, Expressing, Plasmid Preparation, Control

    A) m⁶A -RIP followed by RT-PCR using primers for Taf1d and Ccny. Mouse IgG was used as a control. B) METTL3 knockdown by siRNA (si-Mettl3) followed by RT-PCR to amplify Ccny and Taf1d mRNAs. Scrambled siRNA (si-Scr) was used as a control. C) Downregulation of METTL3 was validated by anti-METTL3 western blotting. Antibody against ACTIN was used as a loading control. D) GC-2spd cells were treated with the methyltransferase inhibitor STC-15 followed by RT-PCR using Ccny and Taf1d primers (left panel). Right panel shows the levels of m⁶A RNA in control (DMSO) and STC-15-treated cells by dot blotting with anti-m6A antibody (two independent replicates are shown). E) In situ hybridization using Ccny -specific probe of DMSO- or STC-15 treated GC-2spd cells. DAPI stains the nuclei (grey). Scale bar: 10 µm. F) GC-2spd cells were transfected with control siRNA (si-Scr), Smg6 - or Piwil1 -targeting siRNA (si-Smg6 or si-Piwil1), empty pcdna3.1 plasmid (control) or HA-SMG6 and FLAG-PIWIL1 overexpressing plasmids before m⁶A - RIP. m6-A-modified Taf1d was detected with RT-PCR from anti-m⁶A RIP samples. Mouse IgG was used as a control in the RIP. G) GC-2spd cells were treated with DMSO, METTL3a1, or STC-15 before anti-SMG6-RIP. SMG6-associated Ccny and Taf1d mRNAs were detected with RT-PCR. Rabbit IgG was used as a control in the RIP. H) Western blot with anti-SMG6 antibody to validate equal IP of SMG6 from DMSO, STC-15, and METTL3a1 treated cells. One representative RIP experiment is shown for each condition.

    Journal: bioRxiv

    Article Title: Chromatoid body integrates piRNA, SMG6 and m⁶A pathways to control mRNAs in the male germline

    doi: 10.64898/2026.03.26.714452

    Figure Lengend Snippet: A) m⁶A -RIP followed by RT-PCR using primers for Taf1d and Ccny. Mouse IgG was used as a control. B) METTL3 knockdown by siRNA (si-Mettl3) followed by RT-PCR to amplify Ccny and Taf1d mRNAs. Scrambled siRNA (si-Scr) was used as a control. C) Downregulation of METTL3 was validated by anti-METTL3 western blotting. Antibody against ACTIN was used as a loading control. D) GC-2spd cells were treated with the methyltransferase inhibitor STC-15 followed by RT-PCR using Ccny and Taf1d primers (left panel). Right panel shows the levels of m⁶A RNA in control (DMSO) and STC-15-treated cells by dot blotting with anti-m6A antibody (two independent replicates are shown). E) In situ hybridization using Ccny -specific probe of DMSO- or STC-15 treated GC-2spd cells. DAPI stains the nuclei (grey). Scale bar: 10 µm. F) GC-2spd cells were transfected with control siRNA (si-Scr), Smg6 - or Piwil1 -targeting siRNA (si-Smg6 or si-Piwil1), empty pcdna3.1 plasmid (control) or HA-SMG6 and FLAG-PIWIL1 overexpressing plasmids before m⁶A - RIP. m6-A-modified Taf1d was detected with RT-PCR from anti-m⁶A RIP samples. Mouse IgG was used as a control in the RIP. G) GC-2spd cells were treated with DMSO, METTL3a1, or STC-15 before anti-SMG6-RIP. SMG6-associated Ccny and Taf1d mRNAs were detected with RT-PCR. Rabbit IgG was used as a control in the RIP. H) Western blot with anti-SMG6 antibody to validate equal IP of SMG6 from DMSO, STC-15, and METTL3a1 treated cells. One representative RIP experiment is shown for each condition.

    Article Snippet: Mouse spermatogonial GC-2spd cells (ATCC® CRL-2196TM, USA) were maintained in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12, D-18900; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, S1810; Biowest) and 1% penicillin–streptomycin (15140-122; Gibco).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Control, Knockdown, Western Blot, In Situ Hybridization, Transfection, Plasmid Preparation, Modification

    A) Immunoprecipitation of PIWIL1 and SMG6 from adult mouse testes. Successful IP was confirmed with Western blotting (WB) using SMG6 and PIWIL1 antibodies. Associated small RNAs were visualized in the UREA-PAGE gel with SYBR Gold staining, revealing a 26-32-nt population consistent with piRNAs length. B) Transfection of PIWIL1-associated testis RNAs into GC2spd cells, followed by RT-qPCR analysis of Ccny target mRNA. Gapdh was used as a reference gene. Data represent mean ± S.D. from two independent experiments. C) Transfection of Ccny -targeting piRNA ( pi-Ccny ) induces Ccny mRNA downregulation in 3T3 cells only when PIWIL1 is overexpressed. Scrambled piRNA ( pi-Scr ) was used as a control for Ccny -targeting piRNA. Empty pcdna3.1. vector (control) was used as a control for FLAG-PIWIL1 overexpression. D) GC-2spd cells were transfected with pi-Scr or pi-Ccny , followed by RT-qPCR using Ccny primers at different time points after transfection to monitor Ccny mRNA levels. E) GC-2spd cells were subjected to siRNA-mediated knockdown of Smg6 prior to transfection with the synthetic pi-Ccny , followed by RT-PCR analysis of Ccny mRNA. F) Same experiment as in (E), but Ccny expression was detected by RT-qPCR. G) GC-2spd cells were treated with the METTL3 inhibitor STC-15 to block m⁶A deposition, followed by transfection with the synthetic pi-Ccny and RT-PCR analysis of Ccny mRNA. For graphs (D,F), Gapdh was used as a reference gene. Data represent mean ± S.D. from three independent experiments; *P < 0.05.

    Journal: bioRxiv

    Article Title: Chromatoid body integrates piRNA, SMG6 and m⁶A pathways to control mRNAs in the male germline

    doi: 10.64898/2026.03.26.714452

    Figure Lengend Snippet: A) Immunoprecipitation of PIWIL1 and SMG6 from adult mouse testes. Successful IP was confirmed with Western blotting (WB) using SMG6 and PIWIL1 antibodies. Associated small RNAs were visualized in the UREA-PAGE gel with SYBR Gold staining, revealing a 26-32-nt population consistent with piRNAs length. B) Transfection of PIWIL1-associated testis RNAs into GC2spd cells, followed by RT-qPCR analysis of Ccny target mRNA. Gapdh was used as a reference gene. Data represent mean ± S.D. from two independent experiments. C) Transfection of Ccny -targeting piRNA ( pi-Ccny ) induces Ccny mRNA downregulation in 3T3 cells only when PIWIL1 is overexpressed. Scrambled piRNA ( pi-Scr ) was used as a control for Ccny -targeting piRNA. Empty pcdna3.1. vector (control) was used as a control for FLAG-PIWIL1 overexpression. D) GC-2spd cells were transfected with pi-Scr or pi-Ccny , followed by RT-qPCR using Ccny primers at different time points after transfection to monitor Ccny mRNA levels. E) GC-2spd cells were subjected to siRNA-mediated knockdown of Smg6 prior to transfection with the synthetic pi-Ccny , followed by RT-PCR analysis of Ccny mRNA. F) Same experiment as in (E), but Ccny expression was detected by RT-qPCR. G) GC-2spd cells were treated with the METTL3 inhibitor STC-15 to block m⁶A deposition, followed by transfection with the synthetic pi-Ccny and RT-PCR analysis of Ccny mRNA. For graphs (D,F), Gapdh was used as a reference gene. Data represent mean ± S.D. from three independent experiments; *P < 0.05.

    Article Snippet: Mouse spermatogonial GC-2spd cells (ATCC® CRL-2196TM, USA) were maintained in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12, D-18900; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, S1810; Biowest) and 1% penicillin–streptomycin (15140-122; Gibco).

    Techniques: Immunoprecipitation, Western Blot, Staining, Transfection, Quantitative RT-PCR, Control, Plasmid Preparation, Over Expression, Knockdown, Reverse Transcription Polymerase Chain Reaction, Expressing, Blocking Assay